“When we perform screening, we're trying to find disease at a stage where treatment is potentially curative, and screening results in improved survival at 1, 3, and 5 years,”1 stated Anne M. Covey, MD, Professor of Radiology, Memorial Sloan Kettering Cancer Center, and a member of the NCCN Guidelines Panel for Hepatobiliary Cancers (HCC). In her discussion at the NCCN 23rd Annual Conference, Dr. Covey not only outlined populations at high risk for HCC but also endorsed the selective use of ultrasound as a preliminary screening tool for early-stage disease.
Zhang B, Yang B, Tang Z. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417–422.
Petrick JL, Braunlin M, Laversanne M et al.. International trends in liver cancer incidence, overall and by histologic subtype. Int J Cancer 2016;139:1534–1545.
Yang JD, Harmsen WS, Slettedahl SW et al.. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 2011;9:617–623.e1.
Park JW, Chen M, Colombo M et al.. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int 2015;35:2155–2166.
Bertuccio P, Turati F, Carioli G et al.. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol 2017;67:302–309.
van Meer S, de Man RA, Coenraad MJ et al.. Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol 2015;63:1156–1163.
Yang HI, Yuen MF, Chan HL et al.. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol 2011;12:568–574.
Lee MH, Lu SN, Yuan Y et al.. Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies. PLoS One 2014;9:e94760.
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(Suppl 1):S35–50.
Fetzer DT, Rodgers SK, Harris AC et al.. Screening and surveillance of hepatocellular carcinoma: an introduction to ultrasound liver imaging reporting and data system. Radiol Clin North Am 2017;55:1197–1209.
Trinchet JC, Chaffaut C, Bourcier V et al.. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology 2011;54:1987–1997.
Santi V, Trevisani F, Gramenzi A et al.. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol 2010;53:291–297.